Edition:
United Kingdom

Cyclacel Pharmaceuticals Inc (CYCC.OQ)

CYCC.OQ on NASDAQ Stock Exchange Capital Market

1.56USD
15 Aug 2018
Change (% chg)

$0.02 (+1.30%)
Prev Close
$1.54
Open
$1.54
Day's High
$1.56
Day's Low
$1.53
Volume
2,563
Avg. Vol
10,707
52-wk High
$2.26
52-wk Low
$1.29

Chart for

About

Cyclacel Pharmaceuticals, Inc. operates in the field of cell cycle biology. The Company has generated various families of anticancer drugs that act on the cell cycle, including nucleoside analogs, cyclin dependent kinase (CDK) inhibitors, polo-like kinase (PLK) inhibitors and Aurora Kinase/vascular endothelial growth factor... (more)

Overall

Beta: 3.74
Market Cap(Mil.): $22.80
Shares Outstanding(Mil.): 11.40
Dividend: --
Yield (%): --

Financials

  CYCC.OQ Industry Sector
P/E (TTM): -- 85.68 32.76
EPS (TTM): -2.42 -- --
ROI: -75.99 1.78 14.61
ROE: -78.45 3.28 16.33

BRIEF-Cyclacel Pharmaceuticals Posts Qtrly Loss Of $2.1 Mln

* CYCLACEL PHARMACEUTICALS REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS

28 Mar 2018

Earnings vs. Estimates